Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...
Rapid Reactions: responding to breaking news. The demands of the 24-hour media machine mean that news journalists often don’t have the luxury of time to track down the best scientists when a science ...